Profile data is unavailable for this security.
About the company
NeuroSense Therapeutics Ltd is an Israel-based clinical-stage pharmaceutical company. The Company is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The Company's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease
- Revenue in USD (TTM)0.00
- Net income in USD-7.51m
- Incorporated2017
- Employees16.00
- LocationNeurosense Therapeutics Ltd11 Hamenofim St., Building BHERZLIYA 4672562IsraelISR
- Phone+972 99531142
- Websitehttps://www.neurosense-tx.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ibio Inc | 225.00k | -15.44m | 23.39m | 16.00 | -- | 1.04 | -- | 103.97 | -7.74 | -10.98 | 0.0586 | 2.47 | 0.0064 | -- | 0.4907 | 14,062.50 | -44.16 | -27.69 | -69.38 | -33.13 | -- | -- | -6,863.56 | -1,862.11 | -- | -- | 0.0689 | -- | -- | -35.52 | 47.31 | -- | -26.66 | -- |
| Neurobo Pharmaceuticals Inc | 0.00 | -25.90m | 23.76m | 8.00 | -- | 1.22 | -- | -- | -4.97 | -4.97 | 0.00 | 2.30 | 0.00 | -- | -- | 0.00 | -89.41 | -95.57 | -117.09 | -135.64 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 10.72 | -- | 75.54 | -- |
| Lisata Therapeutics Inc | 0.00 | -21.07m | 24.21m | 25.00 | -- | 0.6331 | -- | -- | -2.56 | -2.56 | 0.00 | 4.60 | 0.00 | -- | -- | 0.00 | -40.16 | -45.97 | -43.61 | -50.47 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 61.57 | -- | -- | -- |
| Bolt Biotherapeutics Inc | 11.17m | -66.17m | 24.84m | 100.00 | -- | 0.2893 | -- | 2.22 | -1.74 | -1.74 | 0.2938 | 2.24 | 0.0709 | -- | -- | 111,660.00 | -42.03 | -48.32 | -47.37 | -54.03 | -- | -- | -592.57 | -2,267.00 | -- | -- | 0.00 | -- | 37.48 | -- | 21.45 | -- | -6.61 | -- |
| Neurosense Therapeutics Ltd | 0.00 | -7.51m | 25.12m | 16.00 | -- | -- | -- | -- | -0.4392 | -0.4392 | 0.00 | -0.0943 | 0.00 | -- | -- | 0.00 | -154.72 | -- | -470.03 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 18.10 | -- | -- | -- |
| Athira Pharma Inc | 0.00 | -113.45m | 25.37m | 65.00 | -- | 0.3044 | -- | -- | -2.97 | -2.97 | 0.00 | 2.17 | 0.00 | -- | -- | 0.00 | -71.06 | -30.73 | -83.81 | -32.46 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -23.04 | -- | -- | -- |
| Palatin Technologies, Inc. | 4.49m | -29.74m | 25.41m | 30.00 | -- | -- | -- | 5.66 | -1.97 | -1.97 | 0.2981 | -0.0062 | 0.3131 | 0.3713 | 3.08 | 149,669.70 | -207.35 | -55.28 | -1,527.99 | -69.08 | 97.83 | -- | -662.26 | -1,359.14 | 1.01 | -- | -- | -- | -7.49 | -40.52 | -23.71 | -- | 3.31 | -- |
| Lipocine Inc | 4.80m | -8.49m | 25.46m | 17.00 | -- | 1.20 | -- | 5.30 | -1.60 | -1.60 | 0.9012 | 3.97 | 0.1794 | -- | 109.27 | 282,407.70 | -31.72 | -39.32 | -34.05 | -45.87 | -- | -- | -176.80 | -442.26 | -- | -- | 0.00 | -- | -670.16 | -- | -51.99 | -- | -- | -- |
| Cell Source Inc | 0.00 | -6.45m | 25.67m | -- | -- | -- | -- | -- | -0.1627 | -0.1627 | 0.00 | -0.413 | 0.00 | -- | -- | -- | -1,300.91 | -1,758.85 | -- | -- | -- | -- | -- | -- | -- | -5.14 | -- | -- | -- | -- | -3.55 | -- | -- | -- |
| Lipella Pharmaceuticals Inc | 507.20k | -4.14m | 26.34m | 5.00 | -- | 1.84 | -- | 51.92 | -4.95 | -4.95 | 0.5919 | 1.79 | 0.1788 | -- | 16.01 | 101,440.00 | -146.02 | -- | -169.27 | -- | -- | -- | -816.72 | -- | -- | -- | 0.00 | -- | 144.15 | -- | -77.81 | -- | -- | -- |
| Cadrenal Therapeutics Inc | 0.00 | -6.24m | 26.55m | 4.00 | -- | 4.74 | -- | -- | -5.88 | -5.88 | 0.00 | 3.74 | 0.00 | -- | -- | 0.00 | -138.35 | -- | -173.80 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -24.47 | -- | -- | -- |
| GlycoMimetics Inc | 10.00k | -39.11m | 26.59m | 35.00 | -- | 1.33 | -- | 2,659.32 | -0.6071 | -0.6071 | 0.0002 | 0.3111 | 0.0002 | -- | 0.0685 | 285.71 | -90.71 | -43.60 | -103.87 | -47.82 | -- | -- | -391,132.40 | -2,243.52 | -- | -- | 0.00 | -- | -86.67 | -- | 20.97 | -- | -29.82 | -- |
| Estrella Immunopharma Inc | 0.00 | -7.31m | 26.78m | -- | -- | 6.28 | -- | -- | -0.1977 | -0.1977 | 0.00 | 0.1178 | 0.00 | -- | -- | -- | -195.43 | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 34.21 | -- | -- | -- |
Data as of Nov 08 2024. Currency figures normalised to Neurosense Therapeutics Ltd's reporting currency: US Dollar USD
8.65%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Armistice Capital LLCas of 30 Jun 2024 | 1.58m | 8.14% |
| Meitav Mutual Funds Ltd.as of 30 Sep 2024 | 40.00k | 0.21% |
| XTX Markets LLCas of 30 Jun 2024 | 32.65k | 0.17% |
| Commonwealth Equity Services LLCas of 30 Sep 2024 | 12.63k | 0.07% |
| Geode Capital Management LLCas of 30 Jun 2024 | 11.96k | 0.06% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 30 Jun 2024 | 1.50k | 0.01% |
| CWM LLCas of 30 Sep 2024 | 1.00k | 0.01% |
| Qube Research & Technologies Ltd.as of 30 Jun 2024 | 54.00 | 0.00% |
| Schiketanz Capital Advisors GmbHas of 28 Jun 2024 | 0.00 | 0.00% |
| Renaissance Technologies LLCas of 30 Jun 2024 | 0.00 | 0.00% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
